e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Tuberculosis, hydatidosis, empty scheme and pleural disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Functional surgery for chronic obstructive pulmonary disease: a single centre 30 years‘ experience
A. Akopov, V. Varlamov, G. Nikolaev, L. Kiriukhina, Y. Levashev (St. Petersburg, Russian Federation)
Source:
Annual Congress 2005 - Tuberculosis, hydatidosis, empty scheme and pleural disease
Session:
Tuberculosis, hydatidosis, empty scheme and pleural disease
Session type:
Poster Discussion
Number:
3219
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Akopov, V. Varlamov, G. Nikolaev, L. Kiriukhina, Y. Levashev (St. Petersburg, Russian Federation). Functional surgery for chronic obstructive pulmonary disease: a single centre 30 years‘ experience. Eur Respir J 2005; 26: Suppl. 49, 3219
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Predictors of health status in chronic obstructive pulmonary disease patients over three years
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Early supported discharge schemes in older patients with an exacerbation of chronic obstructive pulmonary disease: a real life experience
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
Population health impact of Indacaterol/Glycopyrronium over 4 years in chronic obstructive pulmonary disease
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018
The experiences and expectations of patients with chronic obstructive pulmonary disease (COPD) referred to pulmonary rehabilitation in the UK
Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes
Year: 2010
The year in chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical Year in Review
Year: 2018
Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) at the remote period after radiation exposure
Source: Eur Respir J 2007; 30: Suppl. 51, 338s
Year: 2007
Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020
Effects of pulmonary rehabilitation on different outcomes and at different times in subjects suffering from stable COPD
Source: Annual Congress 2006 - Outcomes in pulmonary rehabilitation
Year: 2006
Does pulmonary rehabilitation improve mortality in patients with chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD
Year: 2017
Five years outcome of Karakoca Resector Balloon dilalation and curetage method in Severe COPD (chronic obstructive pulmonary disease )
Source: International Congress 2018 – Endoscopic lung volume reduction
Year: 2018
Place of the residual volume in the diagnosis of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - New or old physiological parameters in chronic airway disorders?
Year: 2010
Systemic inflammation and increased arterial stiffness in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006
Inflammatory markers in patients attending a rapid access chest pain clinic
Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Year: 2007
Long term pulmonary rehabilitation programs for crhonic obstructive pulmonary disease (COPD). Two years follow-up
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011
Predictors for admission to hospital in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2004 - Pulmonary rehabilitation in acute COPD exacerbations
Year: 2004
Clinical case on COPD: an unexpectedly long story with an unforeseen end
Source: Annual Congress 2007 - Clinical Grand Round: an interactive session
Year: 2007
Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005
Hospitalization burden in chronic obstructive pulmonary disease patients after pulmonary rehabilitation
Source: Annual Congress 2003 - Outcome of integrated care on burden of chronic respiratory failure
Year: 2003
Outpatient pulmonary rehabilitation in severe chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008
Predictors of exacerbations in chronic obstructive pulmonary disease - a first single-centre experience in Croatia
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept